[1]
World Malaria Report, 2016 published by World Health
Organisation.
[2]
Marella, A.; Verma, G.; Shaquiquzzaman, M.; Akhter, M.; Alam, M.M. Malaria: Hitches and Hopes. Mini Rev. Med. Chem., 2014, 14, 453-470.
[3]
Vangapandu, S.; Sachdeva, S.; Jain, M.; Singh, S.; Singh, P.P.; Kaul, C.L.; Jain, R. 8-quinolinamines and their pro prodrug conjugates as potent blood-schizontocidal antimalarial agents. Bioorg. Med. Chem., 2003, 11, 4557-4568.
[4]
Capela, R.; Oliveira, R.; Goncalves, L.M.; Domingos, A.; Gut, J.; Rosenthal, P.J.; Lopes, F.; Moreira, R. Artemisinin-dipeptidylvinyl sulfone hybrid molecules: Design, synthesis and preliminary SAR for antiplasmodial activity and falcipain-2 inhibition. Bioorg. Med. Chem. Lett., 2009, 19, 3229-3232.
[5]
Araujo, N.C.; Barton, V.; Jones, M.; Stocks, P.A.; Ward, S.A.; Davies, J.; Bray, P.G.; Shone, A.E.; Cristiano, M.L.; O’Neill, P.M. Semisynthetic and synthetic 1,2,4-trioxaquines and 1,2,4-trioxolaquines: Synthesis, preliminary SAR and comparison with acridine endoperoxide conjugates. Bioorg. Med. Chem. Lett., 2009, 19, 2038-2043.
[6]
Noedl, H.; Se, Y.; Schaecher, K.; Smith, B.L.; Socheat, D.; Fukuda, M.M. Evidence of artemisinin-resistant malaria in western Cambodia. N. Engl. J. Med., 2008, 359, 2619-2620.
[7]
Cabaret, O.D.; Vical, F.B.; Robert, A.; Meunier, B. Preparation and antimalarial activities of “Trioxaquines”, new modular molecules with a trioxane skeleton linked to a 4-aminoquinoline. ChemBioChem, 2000, 1, 281-283.
[8]
Chauhan, S.S.; Sharma, M.; Chauhan, P.M.S. Trioxaquines: Hybrid molecules for the treatment of malaria. Drug News Perspect., 2010, 23, 632-646.
[9]
Biot, C. Ferroquine: A new weapon in the fight against malaria. Curr. Med. Chem. Antiinfect. Agents, 2004, 3, 135-147.
[10]
Bellot, F.; Cosledan, F.; Vendier, L.; Brocard, J.; Meunier, B.; Robert, A. Trioxaferroquines as new hybrid antimalarial drugs. J. Med. Chem., 2010, 53, 4103-4109.
[11]
Oliveira, R.; Miranda, D.; Magalhaes, J.; Capela, R.; Perry, M.J.; O’Neill, P.M.; Moreira, R.; Lopes, F. From hybrid compounds to targeted drug delivery in antimalarial therapy. Bioorg. Med. Chem., 2015, 23, 5120-5130.
[12]
Arnaud, C.H. Drug hybrids enter the fray. Sci. Technol., 2007, 85, 46-48.
[13]
Meunier, B. Hybrid molecules with a dual mode of action: Dream or Reality? Acc. Chem. Res., 2008, 41, 69-77.
[14]
Cabaret, O.D.; Vical, F.B.; Robert, A.; Meunier, B. Preparation and antimalarial activities of “Trioxaquines”, new modular molecules with a trioxane skeleton linked to a 4-Aminoquinoline. ChemBioChem, 2000, 17, 281-283.
[15]
Cabaret, O.D.; Vical, F.B.; Loup, C.; Robert, A.; Gornitzka, H.; Bonhoure, A.; Vial, H.; Magnaval, J.F.; Seguela, J.P.; Meunier, B. Synthesis and antimalarial activity of trioxaquine derivatives. Chem. Eur. J, 2004, 10, 1625-1636.
[16]
Singh, C.; Malik, H.; Puri, S.K. Synthesis and antimalarial activity of a new series of trioxaquines. Bioorg. Med. Chem., 2004, 12, 1177-1182.
[17]
Agarwal, A.; Srivastava, K.; Puri, S.K.; Chauhan, P.M.S. Syntheses of 2,4,6-trisubstituted triazines as antimalarial agents. Bioorg. Med. Chem. Lett., 2005, 15, 531-533.
[18]
Chiyanzu, I.; Clarkson, C.; Smith, P.J.; Lehman, J.; Gut, J.; Rosenthal, P.J.; Chibale, K. Design, synthesis and anti-plasmodial evaluation in vitro of new 4-aminoquinoline isatin derivatives. Bioorg. Med. Chem., 2005, 13, 3249-3261.
[19]
Katiyar, S.B.; Srivastava, K.; Puri, S.K.; Chauhan, P.M.S. Synthesis of 2- [3,5-substituted pyrazol-1-yl]-4,6-trisubstituted triazine derivatives as antimalarial agents. Bioorg. Med. Chem. Lett., 2005, 15, 4957-4960.
[20]
Burgess, S.J.; Selzer, A.; Kelly, J.X.; Smilkstein, M.J.; Riscoe, M.K.; Peyton, D.H. A chloroquine-like molecule designed to reverse resistance in Plasmodium falciparum. J. Med. Chem., 2006, 49, 5623-5625.
[21]
Biot, C.; Daher, W.; Ndiaye, C.M.; Melnyk, P.; Pradines, B.; Chavain, N.; Pellet, A. Fraisse. L.; Pelinski, L.; Jarry, C.; Brocard. J.; Khalife, J.; Bares, I.F.; Dive D. Probing the role of the covalent linkage of ferrocene into a chloroquine template. J. Med. Chem., 2006, 49, 4707-4714.
[22]
Walsh, J.J.; Coughlan, D.; Heneghan, N.; Gaynor, C.; Bell, A. A novel artemisinin-quinine hybrid with potent antimalarial activity. Bioorg. Med. Chem. Lett., 2007, 17, 3599-3602.
[23]
Vical, F.B.; Lelievre, J.; Berry, A.; Deymier, C.; Cabaret, O.D.; Cazelles, J.; Loup, C.; Robert, A.; Magnaval, J.F.; Meunier, B. Trioxaquines are new antimalarial agents active on all erythrocytic forms, including gametocytes. Antimicrob. Agents Chemother., 2007, 51, 1463-1472.
[24]
Kumar, A.; Srivastava, K.; Kumar, S.R.; Puri, S.K.; P.M.S., Chauhan Synthesis and bioevaluation of hybrid 4-aminoquinoline triazines as a new class of antimalarial agents. Bioorg. Med. Chem. Lett., 2008, 18, 6530-6533.
[25]
Melato, S.; Prosperi, D.; Coghi, P.; Basilico, N.; Monti, D. A combinatorial approach to 2,4,6-trisubstituted triazines with potent antimalarial activity: Combining conventional synthesis and microwave-assistance. ChemMedChem, 2008, 3, 873-876.
[26]
Mishra, S.; Karmodiya, K.; Parasuraman, P.; Surolia, A.; Surolia, N. Design, synthesis, and application of novel triclosan prodrugs as potential antimalarial and antibacterial agents. Bioorg. Med. Chem., 2008, 16, 5536-5546.
[27]
Varotti, F. de P, Botelho, A.C.C.; Andrade, A.A.; de Paula, R.C.; Fagundes, E.M.S.; Valverde, A.; Mayer, L.M.U.; Mendonca, J.S.; de Souza, M.V.N.; Boechat, N.; Krettli, A.U. Synthesis, antimalarial activity, and intracellular targets of MEFAS, a new hybrid compound derived from Mefloquine and Artesunate. Antimicrob. Agents Chemother., 2008, 52, 3868-3874.
[28]
Friebolin, W.; Jannack, B.; Wenzel, N.; Furrer, J.; Oeser, T.; Sanchez, C.P.; Lanzer, M.; Yardley, V.; Becker, K.; Charvet, E.D. Antimalarial dual drugs based on potent inhibitors of glutathione reductase from Plasmodium falciparum. J. Med. Chem., 2008, 51, 1260-1277.
[29]
Gupta, L.; Srivastava, K.; Singh, S.; Puri, S.K. Chauhan. P.M.S. Synthesis of 2-[3-(7-Chloro-quinolin-4-ylamino)-alkyl]-1-(substituted phenyl)-2,3,4,9-tetrahydro-1H-β-carbolines as a new class of antimalarial agents. Bioorg. Med. Chem. Lett., 2008, 18, 3306-3309.
[30]
Acharya, B.N.; Thavaselvam, D.; Kaushik, M.P. Synthesis and antimalarial evaluation of novel pyridine quinoline hybrids. Med. Chem. Res., 2008, 17, 487-494.
[31]
Kumar, A.; Srivastava, K.; Kumar, S.R.; Puri, S.K.; Chauhan, P.M.S. Synthesis of 9-anilinoacridine triazines as new class of hybrid antimalarial agents. Bioorg. Med. Chem. Lett., 2009, 19, 6996-6999.
[32]
Sunduru, N.; Sharma, M.; Srivastava, K.; Rajakumar, S.; Puri, S.K.; Saxena, J.K.; Chauhan, P.M.S. Synthesis of oxalamide and triazine derivatives as a novel class of hybrid 4-aminoquinoline with potent antiplasmodial activity. Bioorg. Med. Chem., 2009, 17, 6451-6462.
[33]
Gemma, S.; Campiani, G.; Butini, S.; Joshi, B.P.; Kukreja, G.; Coccone, S.S.; Bernetti, M.; Persico, M.; Nacci, V.; Fiorini, I.; Novellino, E.; Taramelli, D.; Basilico, N.; Parapini, S.; Yardley, V.; Croft, S.; Maerki, S.K.; Rottmann, M.; Brun, R.; Coletta, M.; Marini, S.; Guiso, G.; Caccia, S.; Fattorusso, C. Combining 4-aminoquinoline- and clotrimazole based pharmacophores toward innovative and potent hybrid antimalarials. J. Med. Chem., 2009, 52, 502-513.
[34]
Jones, M.; Mercer, A.E.; Stocks, P.A.; Pensee, L.J.I.L.; Cosstick, R.; Park, B.K.; Kennedy, M.E.; Piantanida, I.; Ward, S.A.; Davies, J.; Bray, P.G.; Rawe, S.L.; Baird, J.; Charidza, T.; Janneh, O.; o’Neill, P.M. Antitumour and antimalarial activity of artemisinin-acridine hybrids. Bioorg. Med. Chem. Lett., 2009, 19, 2033-2037.
[35]
Musonda, C.C.; Whitlock, G.A.; Witty, M.J.; Brun, R.; Kaiser, M. Chloroquine-astemizole hybrids with potent in vitro and in vivo antiplasmodial activity. Bioorg. Med. Chem. Lett., 2009, 19, 481-484.
[36]
Lombard, M.C.; N’Da, D.D.; Breytenbach, J.C.; Smith, P.J.; Lategan, C.A. Artemisinin-quinoline hybrid-dimers: Synthesis and in vitro antiplasmodial activity. Bioorg. Med. Chem. Lett., 2010, 20, 6975-6977.
[37]
Lombard, M.C.; N’Da, D.D.; Breytenbach, J.C.; Kolesnikova, N.I.; Ba, C.T.V.; Wein, S.; Norman, J.; Denti, P.; Vial, H.; Wiesner, L. Antimalarial and anticancer activities of artemisinin-quinoline hybrid- dimers and pharmacokinetic properties in mice. Eur. J. Pharm. Sci., 2012, 47, 834-841.
[38]
Guantai, E.M.; Ncokazi, K.; Egan, T.J.; Gut, J.; Rosenthal, P.J.; Smith, P.J. Chibale. K. Design, synthesis and in vitro antimalarial evaluation of triazole-linked chalcone and dienone hybrid compounds. Bioorg. Med. Chem., 2010, 18, 8243-8256.
[39]
Kumar, A.; Srivastava, K.; Kumar, S.R.; Puri, S.K.; Chauhan, P.M.S. Synthesis of new 4-aminoquinolines and quinoline-acridine hybrids as antimalarial agents. Bioorg. Med. Chem. Lett., 2010, 20, 7059-7063.
[40]
Bellot, F.; Cosledan, F.; Vendier, L.; Brocard, J.; Meunier, B.; Robert, A. Trioxaferroquines as new hybrid antimalarial drugs. J. Med. Chem., 2010, 53, 4103-4109.
[41]
Bhat, H.R.; Singh, U.P.; Yadav, P.S.; Kumar, V.; Gahtori, P.; Das, A.; Chetia, D.; Prakash, A.; Mahanta, J. Synthesis, characterization and antimalarial activity of hybrid 4-aminoquinoline-1,3,5-triazine derivatives. Arab. J. Chem., 2011, 9, S625-S631.
[42]
Bertinaria, M.; Guglielmo, S.; Rolando, B.; Giorgis, M.; Aragno, C.; Fruttero, R.; Gasco, A.; Parapini, S.; Taramelli, D.; Martins, Y.C.; Carvalho, L.J.M. Amodiaquine analogues containing NO-donor substructures: Synthesis and their preliminary evaluation as potential tools in the treatment of cerebral malaria. Eur. J. Med. Chem., 2011, 46, 1757-1767.
[43]
Lombard, M.C.; N’Da, D.D.; Breytenbach, J.C.; Smith, P.J.; Lategan, C.A. Synthesis, in vitro antimalarial and cytotoxicity of artemisinin-aminoquinoline hybrids. Bioorg. Med. Chem. Lett., 2011, 21, 1683-1686.
[44]
Ruiz, F.A.R.; Sanchez, R.N.G.; Estupinan, S.V.; Barrio, A.G.; Amado, D.F.T.; Solorzano, B.M.P.; Ruiz, J.J.N.; Fernandez, A.R.M.; Kouznetsov, V.V. Synthesis and antimalarial activity of new heterocyclic hybrids based on chloroquine and thiazolidinone scaffolds. Bioorg. Med. Chem., 2011, 19, 4562-4573.
[45]
Kumar, A.; Srivastava, K.; Kumar, S.R.; Siddiqi, M.I.; Puri, S.K.; Sexana, J.K.; Chauhan, P.M.S. 4-Anilinoquinoline triazines: A novel class of hybrid antimalarial agents. Eur. J. Med. Chem., 2011, 46, 676-690.
[46]
Hans, R.H.; Wiid, I.J.F.; van Helden, P.D.; Wan, B.; Franzblau, S.G.; Gut, J.; Rosenthal, P.J.; Chibale, K. Novel thiolactone-isatin hybrids as potential antimalarial and antitubercular agents. Bioorg. Med. Chem. Lett., 2011, 21, 2055-2058.
[47]
Chadwick, J.; Amewu, R.K.; Marti, F.; Garah, F.B.E.; Sharma, R.; Berry, N.G.; Stocks, P.A.; Saward, H.B.; Wittlin, S.; Rottmann, M.; Brun, R.; Taramelli, D.; Parapini, S.; Ward, S.A.; O’Neill, P.M. Antimalarial mannoxanes: Hybrid antimalarial drugs with outstanding oral activity profiles and a potential dual mechanism of action. ChemMedChem, 2011, 6, 1357-1361.
[48]
Quirante, J.; Dubar, F.; Gonzalez, A.; Lopez, C.; Cascante, M.; Cortes, R.; Forfar, I.; Pradines, B.; Biot, C. Ferrocene-indole hybrids for cancer and malaria therapy. J. Organomet. Chem., 2011, 696, 1011-1017.
[49]
Gemma, S.; Camodeca, C.; Coccone, S.S.; Joshi, B.P.; Bernetti, M.; Moretti, V.; Brogi, S.; Bonache, M.C.; Savini, L.; Taramelli, D.; Basilico, N.; Parapini, S.; Rottmann, M.; Brun, R.; Lamponi, S.; Caccia, S.; Guiso, G.; Summer, R.; Martin, R.; Saponara, S.; Gorelli, B.; Novellino, E.; Campiani, G.; Butini, S. Optimization of 4-aminoquinoline/clotrimazole-based hybrid antimalarials: Further structure activity relationships, in vivo studies, and preliminary toxicity profiling. J. Med. Chem., 2012, 55, 6948-6967.
[50]
Manohar, S.; Rajesh, U.C.; Khan, S.I.; Tekwani, B.L.; Rawat, D.S. Novel 4-aminoquinoline-pyrimidine based hybrids with improved in vitro and in vivo antimalarial activity. Med. Chem. Lett., 2012, 3, 555-559.
[51]
Starcevi, K.; Pesic, D.; Toplak, A.; Landek, G.; Alihodzic, S.; Herreros, E.; Ferrer, S.; Spaventi, R.; Peric, M. Novel hybrid molecules based on 15-membered azalide as potential antimalarial agents. Eur. J. Med. Chem., 2012, 49, 365-378.
[52]
Singh, P.; Singh, P.; Kumar, M.; Gut, J.; Rosenthal, P.J.; Kumar, K.; Kumar, V.; Mahajan, M.P.; Bisetty, K. Synthesis, docking and in vitro antimalarial evaluation of bifunctional hybrids derived from β-lactams and 7-chloroquinoline using click chemistry. Bioorg. Med. Chem. Lett., 2012, 22, 57-61.
[53]
Sashidhara, K.V.; Kumar, M.; Modukuri, R.K.; Srivastava, R.K.; Soni, A.; Srivastava, K.; Singh, S.V.; Saxena, J.K.; Gauniyal, H.M.; Puri, S.K. Antiplasmodial activity of novel keto-enamine chalcone-chloroquine based hybrid pharmacophores. Bioorg. Med. Chem., 2012, 20, 2971-2981.
[54]
Sharma, N.; Mohanakrishnan, D.; Shard, A.; Sharma, A. Saima, Sinha, A.K.; Sahal, D. Stilbene-Chalcone hybrids: Design, synthesis, and evaluation as a new class of antimalarial scaffolds that trigger cell death through stage specific apoptosis. J. Med. Chem., 2012, 55, 297-311.
[55]
Sashidhara, K.V.; Avula, S.R.; Palnati, G.R.; Singh, S.V.; Srivastava, K.; Puri, S.K.; Saxena, J.K. Synthesis and in vitro evaluation of new chloroquine-chalcone hybrids against chloroquine-resistant strain of Plasmodium falciparum. Bioorg. Med. Chem. Lett., 2012, 22, 5455-5459.
[56]
Sashidhara, K.V.; Kumar, A.; Dodda, R.P.; Krishna, N.N.; Agarwal, P.; Srivastava, K.; Puri, S.K. Coumarin-trioxane hybrids: Synthesis and evaluation as a new class of antimalarial scaffolds. Bioorg. Med. Chem. Lett., 2012, 22, 3926-3930.
[57]
Gahtori, P.; Ghosh, S.K.; Parida, P.; Prakash, A.; Gogoi, K.; Bhat, H.R.; Singh, U.P. Antimalarial evaluation and docking studies of hybrid phenylthiazolyl-1,3,5-triazine derivatives: A novel and potential antifolate lead for Pf-DHFR-TS inhibition. Exp. Parasitol., 2012, 130, 292-299.
[58]
Singh, K.; Kaur, H.; Chibale, K.; Balzarini, J.; Little, S.; Bharatam, P.V. 2-Aminopyrimidine based 4-aminoquinoline anti-plasmodial agents. Synthesis, biological activity, structure-activity relationship and mode of action studies. Eur. J. Med. Chem., 2012, 52, 82-97.
[59]
Perez, B.C.; Teixeira, C.; Figueiras, M.; Gut, J.; Rosenthal, P.J.; Gomes, J.R.B.; Gomes, P. Novel cinnamic acid/4-aminoquinoline conjugates bearing non-proteinogenic amino acids: Towards the development of potential dual action antimalarials. Eur. J. Med. Chem., 2012, 54, 887-899.
[60]
Boechat, N.; Pinheiro, L.C.S.; Silva, T.S.; Aguiar, A.C.C.; Carvalho, A.S.; Bastos, M.M.; Costa, C.C.P.; Pinheiro, S.; Pinto, A.C.; Mendonca, J.S.; Dutra, K.D.B.; Valverde, A.L.; Filho, O.A.S.; Ceravolo, I.P.; Krettli, A.U. New trifluoromethyl triazolopyrimidines as anti-Plasmodium falciparum agents. Molecules, 2012, 17, 8285-8302.
[61]
Singh, K.; Kaur, H.; Chibale, K.; Balzarini, J. Synthesis of 4-aminoquinoline-pyrimidine hybrids as potent antimalarials and their mode of action studies. Eur. J. Med. Chem., 2013, 66, 314-323.
[62]
Andayi, W.A.; Egan, T.J.; Gut, J.; Rosenthal, P.J.; Chibale, K. Synthesis, antiplasmodial activity, and β- hematin inhibition of hydroxypyridone- chloroquine hybrids. ACS Med. Chem. Lett., 2013, 4, 642-646.
[63]
Njogu, P.M.; Gut, J.; Rosenthal, P.J.; Chibale, K. Design, synthesis, and antiplasmodial activity of hybrid compounds based on (2R,3S)-N-Benzoyl-3-phenylisoserine. ACS Med. Chem. Lett., 2013, 4, 637-641.
[64]
Perez, B.C.; Teixeira, C.; Albuquerque, I.S.; Gut, J.; Rosenthal, P.J.; Gomes, J.R.B.; Prudencio, M.; Gomes, P. N-cinnamoylated chloroquine analogues as dual-stage antimalarial leads. J. Med. Chem., 2013, 56, 556-567.
[65]
Lodige, M.; Lewis, M.D.; Paulsen, E.S.; Esch, H.L.; Pradel, G.; Lehmann, L.; Brun, R.; Bringmann, G.; Mueller, A.K. A primaquine-chloroquine hybrid with dual activity against Plasmodium liver and blood stages. Int. J. Med. Microbiol., 2013, 303, 539-547.
[66]
Pretorius, S.I.; Breytenbach, W.J.; de Kock, C.; Smith, P.J.; N’Da, D.D. Synthesis, characterization and antimalarial activity of quinoline-pyrimidine hybrids. Bioorg. Med. Chem., 2013, 21, 269-277.
[67]
Oliveira, R.; Newton, A.S.; Guedes, R.C.; Miranda, D.; Amewu, R.K.; Srivastava, A.; Gut, J.; Rosenthal, P.J.; O’Neill, P.M.; Ward, S.A.; Lopes, F.; Moreira, R. An endoperoxide-based hybrid approach to deliver falcipain inhibitors inside malaria parasites. ChemMedChem, 2013, 8, 1528-1536.
[68]
Singh, K.; Kaur, H.; Smith, P.; de Kock, C.; Chibale, K.; Balzarini, J. Quinoline-pyrimidine hybrids: Synthesis, antiplasmodial activity, SAR, and mode of action studies. J. Med. Chem., 2014, 57, 435-448.
[69]
Smit, F.J.; N’Da, D.D. Synthesis, in vitro antimalarial activity and cytotoxicity of novel 4-aminoquinolinyl-chalcone amides. Bioorg. Med. Chem., 2014, 22, 1128-1138.
[70]
Joubert, J.P.; Smit, F.J.; du Plessis, L.; Smith, P.J.; N’Da, D.D. Synthesis and in vitro biological evaluation of aminoacridines and artemisinin-acridine hybrids. Eur. J. Pharm. Sci., 2014, 56, 16-27.
[71]
Cloete, T.T.; de Kock, C.; Smith, P.J.; N’Da, D.D. Synthesis, in vitro antiplasmodial activity and cytotoxicity of a series of artemisinine-triazine hybrids and hybrid-dimers. Eur. J. Med. Chem., 2014, 76, 470-481.
[72]
Wang, N.; Wicht, K.J.; Shaban, E.; Ngoc, T.A.; Wang, M.Q.; Hayashi, I.; Hossain, M.I.; Takemasa, Y.; Kaiser, M.; Sayed, I.E.T.E.; Egan, T.J.; Inokuchi, T. Synthesis and evaluation of artesunate-indoloquinoline hybrids as antimalarial drug candidates. MedChemComm, 2014, 5, 927-931.
[73]
Mishra, A.; Batchu, H.; Srivastava, K.; Singh, P.; Shukla, P.K.; Batra, S. Synthesis and evaluation of new diaryl ether and quinoline hybrids as potential antiplasmodial and antimicrobial agents. Bioorg. Med. Chem. Lett., 2014, 24, 1719-1723.
[74]
Andayi, W.A.; Egan, T.J.; Chibale, K. Kojic acid derived hydroxypyridinone-chloroquine hybrids: Synthesis, crystal structure, antiplasmodial activity and β-haematin inhibition. Bioorg. Med. Chem. Lett., 2014, 24, 3263-3267.
[75]
Oliveira, R.; Guedes, R.C.; Meireles, P.; Albuquerque, I.S.; Goncalves, L.M.; Pires, E.; Bronze, M.R.; Gut, J.; Rosenthal, P.J.; Prudencio, M.; Moreira, R.; O’Neill, P.M.; Lopes, F. Tetraoxane-pyrimidine nitrile hybrids as dual stage antimalarials. J. Med. Chem., 2014, 57, 4916-4923.
[76]
Reiter, C.; Karagoz, A.C.; Frohlich, T.; Klein, V.; Zeino, M.; Viertel, K.; Held, J.; Mordmuller, B.; Ozturk, S.E.; Anil, H.; Efferth, T.; Tsogoeva, S.B. Synthesis and study of cytotoxic activity of 1,2,4-trioxane- and egonol-derived hybrid molecules against Plasmodium falciparum and multidrug-resistant human leukemia cells. Eur. J. Med. Chem., 2014, 75, 403-412.
[77]
Boechat, N.; Ferreira, M.D.L.G.; Pinheiro, L.C.S.; Jesus, A.M.L.; Leite, M.M.M.; Junior, C.C.S.; Aguiar, A.C.C.; de Andrade, I.M.; Krettli, A.U. New compounds hybrids 1H-1,2,3-triazole-quinoline against Plasmodium falciparum. Chem. Biol. Drug Des., 2014, 84, 325-332.
[78]
Marella, A.; Akhter, M.; Shaquiquzzaman, M.; Husain, A.; Akhter, W.; Verma, G.; Alam, M.M. Synthesis and in-vitro antimalarial evaluation of Pyrazoline: A new antimalarial Scaffold. J. Pharm. Res., 2014, 8, 77-80.
[79]
Murugan, K.; Raichurkar, A.V.; Khan, F.R.N. Iyer. P.S. Synthesis and in vitro evaluation of novel 8-aminoquinoline-pyrazolopyrimidine hybrids as potent antimalarial agents. Bioorg. Med. Chem. Lett., 2015, 25, 1100-1103.
[80]
Kumar, D.; Khan, S.I.; Tekwani, B.L.; Ponnan, P.; Rawat, D.S. 4-Aminoquinoline-Pyrimidine hybrids: Synthesis, antimalarial activity, heme binding and docking studies. Eur. J. Med. Chem., 2015, 89, 490-502.
[81]
Bhat, H.R.; Singh, U.P.; Thakur, A.; Ghosh, S.K.; Gogoi, K.; Prakash, A.; Singh, R.K. Synthesis, antimalarial activity and molecular docking of hybrid 4-aminoquinoline-1,3,5-triazine derivatives. Exp. Parasitol., 2015, 157, 59-67.
[82]
Raj, R.; Saini, A.; Gut, J.; Rosenthal, P.J.; Kumar, V. Synthesis and in vitro antiplasmodial evaluation of 7-chloroquinoline-chalcone and 7-chloroquinoline-ferrocenylchalcone conjugates. Eur. J. Med. Chem., 2015, 95, 230-239.
[83]
Bertinaria, M.; Sanchez, P.O.; Marini, E.; Guglielmo, S.; Hofer, A.; Martins, Y.C.; Zanini, G.M.; Frangos, J.A.; Gasco, A.; Fruttero, R.; Carvalho, L.J.M. NO-donor dihydroartemisinin derivatives as multitarget agents for the treatment of cerebral malaria. J. Med. Chem., 2015, 58, 7895-7899.
[84]
Lodige, M.; Hiersch, L. Design and synthesis of novel hybrid molecules against malaria. Int. J. Med. Chem., 2015, 2015, 1-23.
[85]
Kaur, H.; Machado, M.; de Kock, C.; Smith, P.; Chibale, K.; Prudencio, M.; Singh, K. Primaquine-pyrimidine hybrids: Synthesis and dual-stage antiplasmodial activity. Eur. J. Med. Chem., 2015, 101, 266-273.
[86]
Bekhit, A.A.; Hassan, A.M.; El-Razik, H.A.A.; El-Miligy, M.M.M.; El-Agroudy, E.J.; Bekhit, A.E.D.A. New heterocyclic hybrids of pyrazole and its bioisosteres: Design, synthesis and biological evaluation as dual acting antimalarial-antileishmanial agents. Eur. J. Med. Chem., 2015, 94, 30-44.
[87]
Kaur, H.; Balzarini, J.; de Kock, C.; Smith, P.J.; Chibale, K.; Singh, K. Synthesis, antiplasmodial activity and mechanistic studies of pyrimidine-5-carbonitrile and quinoline hybrids. Eur. J. Med. Chem., 2015, 101, 52-62.
[88]
Pinheiro, L.C.S.; Boechat, N.; Ferreira, M.D.L.G.; Junior, C.C.S.; Jesus, A.M.L.; Leite, M.M.M.; Souza, N.B.; Krettli, A.U. Anti-Plasmodium falciparum activity of quinoline-sulfonamide hybrids. Bioorg. Med. Chem., 2015, 23, 5979-5984.
[89]
Reiter, C.; Frohlich, T.; Zeino, M.; Marschall, M.; Bahsi, H.; Leidenberger, M.; Friedrich, O.; Kappes, B.; Hampel, F.; Efferth, T.; Tsogoeva, S.B. New efficient artemisinin derived agents against human leukemia cells, human cytomegalovirus and Plasmodium falciparum: 2nd generation 1,2,4-trioxane-ferrocene hybrids. Eur. J. Med. Chem., 2015, 97, 164-172.
[90]
Marella, A.; Akhter, M.; Shaquiquzzaman, M.; Tanwar, O.; Verma, G.; Alam, M.M. Synthesis, 3D-QSAR and docking studies of pyrimidine nitrile-pyrazoline: A novel class of hybrid antimalarial agents. Med. Chem. Res., 2015, 24, 1018-1037.
[91]
Marella, A.; Shaquiquzzaman, M.; Akhter, M.; Verma, G.; Alam, M.M. Novel pyrazole-pyrazoline hybrids endowed with thioamide as antimalarial agents: Their synthesis and 3D-QSAR studies. J. Enzyme Inhib. Med. Chem., 2015, 30, 597-606.
[92]
Dana, S.; Keshri, S.K.; Shukla, J.; Vikramdeo, K.S.; Mondal, N.; Mukhopadhyay, P.; Dhar, S.K. Design, synthesis and evaluation of bifunctional acridinine-naphthalenediimide redox-active conjugates as antimalarials. ACS Omega, 2016, 1, 318-333.
[93]
Sahu, S.; Ghosh, S.K.; Kalita, J.; Dutta, M.; Bhat, H.R. Design, synthesis and antimalarial screening of some hybrid 4-aminoquinoline-triazine derivatives against pf-DHFR-TS. Exp. Parasitol., 2016, 163, 38-45.
[94]
Pandey, A.K.; Sharma, S.; Pandey, M.; Alam, M.M.; Shaquiquzzaman, M.; Akhter, M. 4,5-Dihydrooxazole-pyrazoline hybrids: Synthesis and their evaluation as potential antimalarial agents. Eur. J. Med. Chem., 2016, 123, 476-486.
[95]
Silva, T.B.; Bernardino, A.M.R.; Ferreira, M.D.L.G.; Rogerio, K.R.; Carvalho, L.J.M.; Boechat, N.; Pinheiro, L.C.S. Design, synthesis and anti-P. falciparum activity of pyrazolopyridine-sulfonamide derivatives. Bioorg. Med. Chem., 2016, 24, 4492-4498.
[96]
Carvalho, R.C.C.; Martins, W.A.; Silva, T.P.; Kaiser, C.R.; Bastos, M.M.; Pinheiro, L.C.S.; Krettli, A.U.; Boechat, N. New pentasubstituted pyrrole hybrid atorvastatin-quinoline derivatives with antiplasmodial activity. Bioorg. Med. Chem. Lett., 2016, 26, 1881-1884.
[97]
Reddy, P.L.; Khan, S.I.; Ponnan, P.; Tripathi, M.; Rawat, D.S. Design, synthesis and evaluation of 4-Aminoquinoline-purine hybrids as potential antiplasmodial agents. Eur. J. Med. Chem., 2017, 126, 675-686.
[98]
Kholiya, R.; Khan, S.I.; Bahuguna, A.; Tripathi, M.; Rawat, D.S. N-piperonyl substitution on aminoquinoline-pyrimidine hybrids: Effect on the antiplasmodial potency. Eur. J. Med. Chem., 2017, 131, 126-140.
[99]
Maurya, S.S.; Khan, S.I.; Bahuguna, A.; Kumar, D.; Rawat, D.S. Synthesis, antimalarial activity, heme binding and docking studies of N-substituted 4- aminoquinoline-pyrimidine molecular hybrids. Eur. J. Med. Chem., 2017, 129, 175-185.
[100]
Azeredo, L.F.S.P.; Coutinho, J.P.; Jabor, V.A.P.; Feliciano, P.R.; Nonato, M.C.; Kaiser, C.R.; Menezes, C.M.S.; Hammes, A.S.O.; Caffarena, E.R.; Hoelz, L.V.B.; de Souza, N.B.; Pereira, G.A.N.; Ceravolo, I.P.; Krettli, A.U.; Boechat, N. Evaluation of 7-arylaminopyrazolo[1,5-a] pyrimidines as anti-Plasmodium falciparum, antimalarial, and Pf-dihydroorotate dehydrogenase inhibitors. Eur. J. Med. Chem., 2017, 126, 72-83.
[101]
Pearce, A.N.; Kaiser, M.; Copp, B.R. Synthesis and antimalarial evaluation of artesunate-polyamine and trioxolanepolyamine conjugates. Eur. J. Med. Chem., 2017, 140, 595-603.
[102]
Kumar, S.; Saini, A.; Gut, J.; Rosenthal, P.J.; Raj, R.; Kumar, V. 4-Aminoquinoline-chalcone/-N-acetylpyrazoline conjugates: Synthesis and antiplasmodial evaluation. Eur. J. Med. Chem., 2017, 138, 993-1001.
[103]
Gayam, V.; Ravi, S. Cinnamoylated chloroquine analogues: A new structural class of antimalarial agents. Eur. J. Med. Chem., 2017, 135, 382-391.
[104]
Devender, N.; Gunjan, S.; Tripathi, R.; Tripathi, R.T. Synthesis and antiplasmodial activity of novel indoleamide derivatives bearing sulfonamide and triazole pharmacophores. Eur. J. Med. Chem., 2017, 131, 171-184.
[105]
Saikrishna, B.; Kumari, M.K.; Vijjulatha, M.; Allanki, A.D.; Prasad, R.; Sijwali, P.S. Synthesis and evaluation of Naphthyl bearing 1,2,3-Triazole analogs as antiplasmodial agents, cytotoxicity and docking studies. Bioorg. Med. Chem., 2017, 25, 221-232.
[106]
Mishra, V.K.; Mishra, M.; Kashaw, V.; Kashaw, S.K. Synthesis of 1,3,5-trisubstituted pyrazolines as potential antimalarial and antimicrobial agents. Bioorg. Med. Chem., 2017, 25, 1949-1962.
[107]
Patel, T.S.; Vanparia, S.F.; Patel, U.H.; Dixit, R.B.; Chudasama, C.J.; Patel, B.D.; Dixit, B.C. Novel 2,3-disubstituted quinazoline-4(3H)-one molecules derived from amino acid linked sulphonamide as a potent malarial antifolates for DHFR inhibition. Eur. J. Med. Chem., 2017, 129, 251-265.
[108]
Yadav, N.; Agarwal, D.; Kumar, S.; Dixit, A.K.; Gupta, A.D.; Awasthi, S.K. In vitro antiplasmodial efficacy of synthetic coumarin-triazole analogs. Eur. J. Med. Chem., 2018, 145, 735-745.
[109]
Chopra, R.; Chibale, K.; Singh, K. Pyrimidine-chloroquinoline hybrids: Synthesis and antiplasmodial activity. Eur. J. Med. Chem., 2018, 148, 39-53.
[110]
Capela, R.; Magalhaes, J.; Miranda, D.; Machado, M.; Vaz, M.S.; Albuquerque, I.S.; Sharma, M.; Gut, J.; Rosenthal, P.J.; Frade, R.; Perry, M.J. Eur. J. Med. Chem., 2018, 149, 69-78.
Download PDF Flyer